Does IPILIMUMAB Cause Leukocytosis? 40 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Leukocytosis have been filed in association with IPILIMUMAB (YERVOY). This represents 0.1% of all adverse event reports for IPILIMUMAB.
40
Reports of Leukocytosis with IPILIMUMAB
0.1%
of all IPILIMUMAB reports
10
Deaths
28
Hospitalizations
How Dangerous Is Leukocytosis From IPILIMUMAB?
Of the 40 reports, 10 (25.0%) resulted in death, 28 (70.0%) required hospitalization, and 8 (20.0%) were considered life-threatening.
Is Leukocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IPILIMUMAB. However, 40 reports have been filed with the FAERS database.
What Other Side Effects Does IPILIMUMAB Cause?
Death (3,710)
Malignant neoplasm progression (3,296)
Diarrhoea (2,557)
Off label use (2,097)
Colitis (1,988)
Pyrexia (1,796)
Rash (1,556)
Fatigue (1,447)
Intentional product use issue (1,329)
Nausea (1,169)
What Other Drugs Cause Leukocytosis?
CLOZAPINE (1,460)
PREDNISONE (419)
ACETAMINOPHEN (356)
METFORMIN (345)
RUXOLITINIB (320)
RITUXIMAB (272)
METHYLPREDNISOLONE (252)
AMLODIPINE (250)
IBRUTINIB (243)
DEXAMETHASONE (235)
Which IPILIMUMAB Alternatives Have Lower Leukocytosis Risk?
IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE
IPILIMUMAB vs IPRATROPIUM
IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS
IPILIMUMAB vs IPTACOPAN
IPILIMUMAB vs IRBESARTAN